Ohar JA[au] - Search Results

Year	Number of Results
1989	1
1990	1
1991	1
1992	1
1993	2
1994	1
1996	2
1997	2
1998	1
2001	2
2004	1
2006	1
2007	2
2009	1
2010	4
2012	2
2013	2
2014	2
2015	8
2016	6
2017	4
2018	5
2019	6
2020	5
2021	3
2022	2

1

Peak Inspiratory Flow Rate in Chronic Obstructive Pulmonary Disease: Implications for Dry Powder Inhalers.

Ghosh S, Ohar JA, Drummond MB. Ghosh S, et al. Among authors: ohar ja. J Aerosol Med Pulm Drug Deliv. 2017 Dec;30(6):381-387. doi: 10.1089/jamp.2017.1416. Epub 2017 Sep 21. J Aerosol Med Pulm Drug Deliv. 2017. PMID: 28933581 Free PMC article. Review.

2

Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline.

Macrea M, Oczkowski S, Rochwerg B, Branson RD, Celli B, Coleman JM 3rd, Hess DR, Knight SL, Ohar JA, Orr JE, Piper AJ, Punjabi NM, Rahangdale S, Wijkstra PJ, Yim-Yeh S, Drummond MB, Owens RL. Macrea M, et al. Among authors: ohar ja. Am J Respir Crit Care Med. 2020 Aug 15;202(4):e74-e87. doi: 10.1164/rccm.202006-2382ST. Am J Respir Crit Care Med. 2020. PMID: 32795139 Free PMC article.

3

Risks May Not Be Reasons for COPD Readmissions.

Ohar JA. Ohar JA. Ann Am Thorac Soc. 2015 Sep;12(9):1259-60. doi: 10.1513/AnnalsATS.201507-444ED. Ann Am Thorac Soc. 2015. PMID: 26372799 No abstract available.

4

Will Remotely Based Pulmonary Rehabilitation Water Down Its Effectiveness?

Rawal H, Cornelison SD, Flynn SM, Ohar JA. Rawal H, et al. Among authors: ohar ja. Life (Basel). 2021 Nov 20;11(11):1270. doi: 10.3390/life11111270. Life (Basel). 2021. PMID: 34833145 Free PMC article. Review.

5

Nebulized arformoterol: what is its place in the management of COPD?

Miles MC, Donohue JF, Ohar JA. Miles MC, et al. Among authors: ohar ja. Ther Adv Respir Dis. 2013 Apr;7(2):81-6. doi: 10.1177/1753465812465784. Epub 2012 Nov 12. Ther Adv Respir Dis. 2013. PMID: 23147985 Free article. Review.

6

New combination therapies for asthma.

Donohue JF, Ohar JA. Donohue JF, et al. Among authors: ohar ja. Curr Opin Pulm Med. 2001 Mar;7(2):62-8. doi: 10.1097/00063198-200103000-00002. Curr Opin Pulm Med. 2001. PMID: 11224725 Review.

7

Optimum bronchodilator combinations in chronic obstructive pulmonary disease: what is the current evidence?

Miles MC, Donohue JF, Ohar JA. Miles MC, et al. Among authors: ohar ja. Drugs. 2012 Feb 12;72(3):301-8. doi: 10.2165/11598580-000000000-00000. Drugs. 2012. PMID: 22316346 Review.

8

The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device.

Tashkin DP, Ohar JA, Koltun A, Allan R, Ward JK. Tashkin DP, et al. Among authors: ohar ja. Pulm Med. 2021 Mar 17;2021:8881895. doi: 10.1155/2021/8881895. eCollection 2021. Pulm Med. 2021. PMID: 33815843 Free PMC article. Review.

9

Dual therapy strategies for COPD: the scientific rationale for LAMA + LABA.

Cohen JS, Miles MC, Donohue JF, Ohar JA. Cohen JS, et al. Among authors: ohar ja. Int J Chron Obstruct Pulmon Dis. 2016 Apr 15;11:785-97. doi: 10.2147/COPD.S54513. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27143870 Free PMC article. Review.

10

The Role of Guaifenesin in the Management of Chronic Mucus Hypersecretion Associated with Stable Chronic Bronchitis: A Comprehensive Review.

Ohar JA, Donohue JF, Spangenthal S. Ohar JA, et al. Chronic Obstr Pulm Dis. 2019 Oct 23;6(4):341-9. doi: 10.15326/jcopdf.6.4.2019.0139. Chronic Obstr Pulm Dis. 2019. PMID: 31647856 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results